Back to Results
First PageMeta Content



Intersect ENT Announces FDA Submission of NOVA Bioabsorbable Steroid Releasing Implant for Patients with Chronic Sinus Disease MENLO PARK, Calif.—Aug. 1, 2016—Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to
Add to Reading List

Document Date: 2016-07-29 19:00:51


Open Document

File Size: 29,02 KB

Share Result on Facebook